Direct RNA-based detection and differentiation of CTX-MType extended-spectrum β-lactamases (ESBL)

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Stein, Claudia ^a   Makarewicz, Oliwia ^a   Pfeifer, Yvonne ^b   Brandt, Christian ^a   Ramos, João Costa ^a   Klinger, Mareike ^a   Pletz, Mathias W ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; MESSENGER RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; CTM X GENE; ENTEROBACTERIACEAE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; SEQUENCE ALIGNMENT;

BETA-LACTAMASES; ESCHERICHIA COLI; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA;

EID: 84892421050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080079     Document Type: Article

References (38)

1. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686. doi:10.1128/CMR.18.4.657-686. 2005. PubMed: 16223952.
2. Chong Y, Ito Y, Kamimura T (2011) Genetic evolution and clinical impact in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol 11: 1499-1504. doi: 10.1016/j.meegid.2011.06.001. PubMed: 21689785.
3. Lu SY, Zhang YL, Geng SN, Li TY, Ye ZM et al. (2010) High diversity of extended-spectrum beta-lactamase-producing bacteria in an urban river sediment habitat. Appl Environ Microbiol 76: 5972-5976. doi: 10.1128/AEM.00711-10. PubMed: 20639374.
4. Ma J, Liu JH, Lv L, Zong Z, Sun Y et al. (2012) Characterization of extended-spectrum beta-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm. Appl Environ Microbiol 78: 3668-3673. doi:10.1128/AEM.07507-11. PubMed: 22407683.
5. Ruppé E, Hem S, Lath S, Gautier V, Ariey F et al. (2009) CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis 15: 741-748. doi:10.3201/eid1505.071299. PubMed: 19402960.
6. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48: 1-14. doi:10.1128/AAC.48.1.1-14. 2004. PubMed: 14693512.
7. Pletz MW, Wellinghausen N, Welte T (2011) Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 37: 1069-1076. doi:10.1007/s00134-011-2245-x. PubMed: 21573947.
8. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH (2012) Extended-spectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18: 646-655.
9. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B et al. (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51: 1987-1994. doi:10.1128/AAC.01509-06. PubMed: 17387156.
10. Marra AR, Wey SB, Castelo A, Gales AC, Cal RG et al. (2006) Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis 6: 24. doi:10.1186/1471-2334- 6-24. PubMed: 16478537.
11. Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E et al. (2006) Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50: 498-504. doi:10.1128/AAC.50.2.498-504. 2006. PubMed: 16436702.
12. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB et al. (2005) Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 165: 1375-1380. doi:10.1001/archinte.165.12.1375. PubMed: 15983286.
13. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34: 17-60. doi:10.1007/s00134-007-0934-2. PubMed: 18058085.
14. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE et al. (2010) Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger. Med Sci 8: Doc14.
15. Dalhoff K, Abele-Horn M, Andreas S, Bauer T, von Baum H et al. (2012) Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. Pneumologie 66: 707-765. doi:10.1055/s-0032-1325924. PubMed: 23225407.
16. ATS/IDSA (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416. doi:10.1164/rccm.200405-644ST. PubMed: 15699079.
17. Kumar A (2009) Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin 25: 733-751, viii doi:10.1016/j.ccc.2009.08.004. PubMed: 19892250.
18. Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P et al. (2011) EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect, 19: 141-60. PubMed: 22117544.
19. Hanson ND, Sanders CC (1999) Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae. Curr Pharm Des 5: 881-894. PubMed: 10539994.
20. (1987) Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance. Eur J Clin Microbiol Infect Dis 6: 460-466. doi:10.1007/BF02013111.
21. Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J et al. (2009) Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 58: 912-922. doi: 10.1099/jmm.0.005850-0. PubMed: 19502377.
22. Pfeifer Y, Matten J, Rabsch W (2009) Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg Infect Dis 15: 1533-1535. doi:10.3201/eid1509.090567. PubMed: 19788837.
23. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Göttig S et al. (2011) Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother 66: 1998-2001. doi:10.1093/jac/dkr256. PubMed: 21693460.
24. Sambrook J, Fritsch EF, Sambrook J (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
25. CLSI (2012) Clinical and Laboratory Standards Institute. Perform Standards Antimicrob Susceptibility Test Twentysecond Informational Supplement: M100-MS22. Wayne, PA, USA
26. Chevenet F, Brun C, Bañuls AL, Jacq B, Christen R (2006) TreeDyn: towards dynamic graphics and annotations for analyses of trees. BMC Bioinformatics 7: 439. doi:10.1186/1471-2105-7-439. PubMed: 17032440.
27. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ (2000) CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 14: 137-142. doi:10.1016/S0924-8579(99)00165-X. PubMed: 10720804.
28. Novais A, Cantón R, Valverde A, Machado E, Galán JC et al. (2006) Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-alpha, and IncFI groups. Antimicrob Agents Chemother 50: 2741-2750. doi:10.1128/AAC.00274-06. PubMed: 16870767.
29. Cantón R, Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9: 466-475. doi:10.1016/j.mib.2006.08.011. PubMed: 16942899.
30. Canton R, Gonzalez-Alba JM, Galan JC (2012) CTX-M Enzymes: Origin and Diffusion. Front Microbiol 3: 110. PubMed: 22485109.
31. Pfeifer Y, Cullik A, Witte W (2010) Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol IJMM 300: 371-379. doi:10.1016/j.ijmm.2010.04.005. PubMed: 20537585.
32. Novais A, Cantón R, Coque TM, Moya A, Baquero F et al. (2008) Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance. Antimicrob Agents Chemother 52: 2377-2382. doi:10.1128/AAC.01658-07. PubMed: 18443114.
33. Naas T, Oxacelay C, Nordmann P (2007) Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing. Antimicrob Agents Chemother 51: 223-230. doi: 10.1128/AAC.00611-06. PubMed: 17088478.
34. Bonnet R, Recule C, Baraduc R, Chanal C, Sirot D et al. (2003) Effect of D240G substitution in a novel ESBL CTX-M-27. J Antimicrob Chemother 52: 29-35. doi:10.1093/jac/dkg256. PubMed: 12775683.
35. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E et al. (2009) Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 53: 1868-1873. doi:10.1128/AAC.00782-08. PubMed: 19223638.
36. Bloos F, Sachse S, Kortgen A, Pletz MW, Lehmann M et al. (2012) Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational Study. PLOS ONE 7: e46003. doi:10.1371/journal.pone.0046003. PubMed: 23029360.
37. Pfeifer Y, Schlatterer K, Engelmann E, Schiller RA, Frangenberg HR et al. (2012) Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother 56: 2125-2128. doi:10.1128/AAC.05315-11. PubMed: 22290940.
38. Eller C, Simon S, Miller T, Frick JS, Prager R et al. (in press) Presence of beta-lactamases in extended-spectrum cephalosporin-resistant Salmonella strains of 30 different serovars in Germany 2005-2011. J Antimicrob Chemother.